SMC HEALTHCARE

Specialized Medical Company

4019StocksTadawulHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Ratios

1-5

	CurrentMar 10, 2026	Q1 2026Mar 31, 2026	Q4 2025Dec 31, 2025	Q3 2025Sep 30, 2025	Q2 2025Jun 30, 2025
Market & Price
Market Capitalization	3.88B	4.64B	4.51B	4.85B	5.74B
Enterprise Value	4.60B	5.21B	5.12B	5.54B	6.54B
Last Close Price	15.53	18.19	16.92	18.20	21.51
Valuation Multiples
Forward PE (Next 12M Est.)	15.35	14.92	14.35	16.66	—
PE Ratio	14.43	17.22	16.94	30.63	37.96
PEG Ratio	1.54	0.83	0.80	0.93	—
PS Ratio	2.50	2.99	2.93	3.33	3.91
PB Ratio	3.81	4.55	3.80	4.59	5.78
P/TBV Ratio	3.81	4.55	3.80	4.59	5.78
P/FCF Ratio	19.43	23.20	19.76	14.73	—
P/OCF Ratio	13.49	16.11	13.97	11.59	—
EV/Sales Ratio	2.97	3.36	3.33	3.80	4.46
EV/EBITDA Ratio	13.88	17.41	17.23	21.54	25.66
EV/EBIT Ratio	19.53	22.14	21.81	28.48	33.71
EV/FCF Ratio	23.01	26.08	22.45	16.82	—
Leverage & Capital
Debt / Equity Ratio	0.81	0.81	0.70	0.84	0.95
Debt / EBITDA Ratio	2.50	3.12	2.16	2.28	3.28
Debt / FCF Ratio	4.14	4.14	3.62	2.70	—
Net Debt / Equity Ratio	0.70	0.70	0.49	0.58	0.69
Net Debt / EBITDA Ratio	2.39	2.39	1.94	2.39	2.70
Net Debt / FCF Ratio	3.58	3.58	2.53	1.87	2.39
Efficiency & Liquidity
Asset Turnover	0.66	0.69	0.66	0.68	0.71
Inventory Turnover	39.29	38.68	46.39	38.42	39.35
Quick Ratio	0.95	0.95	1.30	1.17	1.09
Current Ratio	1.10	1.10	1.42	1.30	1.19
Returns & Yields
Return on Equity (ROE)	+11.8%	+47.7%	+25.8%	+15.7%	+14.1%
Return on Assets (ROA)	+4.4%	+7.6%	+7.9%	+5.4%	+4.9%
Return on Invested Capital (ROIC)	+2.3%	+4.2%	+4.3%	+2.8%	+2.4%
Return on Capital Employed (ROCE)	+14.2%	+14.2%	+12.7%	+11.6%	+11.9%
Earnings Yield	+6.9%	+5.8%	+5.9%	+3.3%	+2.6%
FCF Yield	+5.1%	+4.3%	+5.1%	+6.8%	+5.0%
Dividend Yield	+2.1%	—	+1.9%	—	—
Payout Ratio	+74.3%	+614.4%	—	—	—
Buyback Yield / Dilution	—	—	—	—	—
Total Shareholder Return	+2.1%	—	+1.9%	—	—

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Ratios

1-5

	CurrentMar 10, 2026	Q1 2026Mar 31, 2026	Q4 2025Dec 31, 2025	Q3 2025Sep 30, 2025	Q2 2025Jun 30, 2025
Market & Price
Market Capitalization	3.88B	4.64B	4.51B	4.85B	5.74B
Enterprise Value	4.60B	5.21B	5.12B	5.54B	6.54B
Last Close Price	15.53	18.19	16.92	18.20	21.51
Valuation Multiples
Forward PE (Next 12M Est.)	15.35	14.92	14.35	16.66	—
PE Ratio	14.43	17.22	16.94	30.63	37.96
PEG Ratio	1.54	0.83	0.80	0.93	—
PS Ratio	2.50	2.99	2.93	3.33	3.91
PB Ratio	3.81	4.55	3.80	4.59	5.78
P/TBV Ratio	3.81	4.55	3.80	4.59	5.78
P/FCF Ratio	19.43	23.20	19.76	14.73	—
P/OCF Ratio	13.49	16.11	13.97	11.59	—
EV/Sales Ratio	2.97	3.36	3.33	3.80	4.46
EV/EBITDA Ratio	13.88	17.41	17.23	21.54	25.66
EV/EBIT Ratio	19.53	22.14	21.81	28.48	33.71
EV/FCF Ratio	23.01	26.08	22.45	16.82	—
Leverage & Capital
Debt / Equity Ratio	0.81	0.81	0.70	0.84	0.95
Debt / EBITDA Ratio	2.50	3.12	2.16	2.28	3.28
Debt / FCF Ratio	4.14	4.14	3.62	2.70	—
Net Debt / Equity Ratio	0.70	0.70	0.49	0.58	0.69
Net Debt / EBITDA Ratio	2.39	2.39	1.94	2.39	2.70
Net Debt / FCF Ratio	3.58	3.58	2.53	1.87	2.39
Efficiency & Liquidity
Asset Turnover	0.66	0.69	0.66	0.68	0.71
Inventory Turnover	39.29	38.68	46.39	38.42	39.35
Quick Ratio	0.95	0.95	1.30	1.17	1.09
Current Ratio	1.10	1.10	1.42	1.30	1.19
Returns & Yields
Return on Equity (ROE)	+11.8%	+47.7%	+25.8%	+15.7%	+14.1%
Return on Assets (ROA)	+4.4%	+7.6%	+7.9%	+5.4%	+4.9%
Return on Invested Capital (ROIC)	+2.3%	+4.2%	+4.3%	+2.8%	+2.4%
Return on Capital Employed (ROCE)	+14.2%	+14.2%	+12.7%	+11.6%	+11.9%
Earnings Yield	+6.9%	+5.8%	+5.9%	+3.3%	+2.6%
FCF Yield	+5.1%	+4.3%	+5.1%	+6.8%	+5.0%
Dividend Yield	+2.1%	—	+1.9%	—	—
Payout Ratio	+74.3%	+614.4%	—	—	—
Buyback Yield / Dilution	—	—	—	—	—
Total Shareholder Return	+2.1%	—	+1.9%	—	—